Crescent Capital BDC (NASDAQ:CCAP) Lowered to “Sell” Rating by Wall Street Zen

Wall Street Zen lowered shares of Crescent Capital BDC (NASDAQ:CCAPFree Report) from a hold rating to a sell rating in a research report report published on Saturday.

A number of other equities analysts have also recently issued reports on CCAP. Oppenheimer cut Crescent Capital BDC from an “outperform” rating to a “market perform” rating and cut their price target for the stock from $19.00 to $16.00 in a report on Friday. Wells Fargo & Company cut their price target on Crescent Capital BDC from $13.00 to $12.00 and set an “equal weight” rating on the stock in a report on Friday. B. Riley Financial restated a “neutral” rating on shares of Crescent Capital BDC in a report on Friday. Keefe, Bruyette & Woods cut their price target on Crescent Capital BDC from $15.50 to $15.00 and set an “outperform” rating on the stock in a report on Thursday, April 16th. Finally, LADENBURG THALM/SH SH cut their price target on Crescent Capital BDC from $16.00 to $15.00 and set a “buy” rating on the stock in a report on Friday. Two research analysts have rated the stock with a Buy rating and four have issued a Hold rating to the company’s stock. According to data from MarketBeat, Crescent Capital BDC currently has an average rating of “Hold” and a consensus price target of $14.30.

Check Out Our Latest Analysis on CCAP

Crescent Capital BDC Trading Down 7.2%

NASDAQ CCAP opened at $11.13 on Friday. The business has a 50 day simple moving average of $12.93 and a 200 day simple moving average of $13.76. Crescent Capital BDC has a one year low of $11.03 and a one year high of $16.03. The stock has a market capitalization of $410.14 million, a P/E ratio of 27.15 and a beta of 0.59. The company has a debt-to-equity ratio of 1.35, a current ratio of 1.53 and a quick ratio of 1.22.

Crescent Capital BDC (NASDAQ:CCAPGet Free Report) last posted its quarterly earnings results on Wednesday, May 13th. The company reported $0.42 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.41 by $0.01. The firm had revenue of ($6.84) million for the quarter, compared to analysts’ expectations of $39.58 million. Crescent Capital BDC had a return on equity of 9.34% and a net margin of 9.26%. Research analysts expect that Crescent Capital BDC will post 1.61 earnings per share for the current year.

Crescent Capital BDC Announces Dividend

The company also recently announced a special dividend, which will be paid on Tuesday, December 15th. Investors of record on Monday, November 30th will be issued a $0.03 dividend. This represents a dividend yield of 107.0%. The ex-dividend date is Monday, November 30th. Crescent Capital BDC’s dividend payout ratio (DPR) is currently 409.76%.

Hedge Funds Weigh In On Crescent Capital BDC

A number of large investors have recently modified their holdings of the company. North Ground Capital lifted its holdings in shares of Crescent Capital BDC by 99.8% in the 4th quarter. North Ground Capital now owns 835,312 shares of the company’s stock worth $11,736,000 after purchasing an additional 417,312 shares in the last quarter. Invesco Ltd. lifted its holdings in shares of Crescent Capital BDC by 1,504.9% in the 4th quarter. Invesco Ltd. now owns 659,696 shares of the company’s stock worth $9,269,000 after purchasing an additional 618,590 shares in the last quarter. Franklin Resources Inc. lifted its holdings in shares of Crescent Capital BDC by 7.0% in the 3rd quarter. Franklin Resources Inc. now owns 540,460 shares of the company’s stock worth $7,707,000 after purchasing an additional 35,534 shares in the last quarter. Bulldog Investors LLP lifted its holdings in shares of Crescent Capital BDC by 4.6% in the 4th quarter. Bulldog Investors LLP now owns 457,518 shares of the company’s stock worth $6,428,000 after purchasing an additional 20,000 shares in the last quarter. Finally, Mariner LLC lifted its holdings in shares of Crescent Capital BDC by 0.3% in the 4th quarter. Mariner LLC now owns 451,774 shares of the company’s stock worth $6,369,000 after purchasing an additional 1,492 shares in the last quarter. 49.46% of the stock is currently owned by institutional investors.

More Crescent Capital BDC News

Here are the key news stories impacting Crescent Capital BDC this week:

About Crescent Capital BDC

(Get Free Report)

Crescent Capital BDC, Inc is a closed-end, externally managed business development company that provides flexible financing solutions to middle market companies in the United States. Trading on the Nasdaq under the ticker CCAP, the firm offers investors exposure to a diversified portfolio of debt and equity instruments, targeting businesses with attractive risk-adjusted return profiles. Its primary objective is to generate current income through interest payments and potential capital appreciation via selective equity co-investments.

The company’s investment strategy emphasizes senior secured loans, unsecured second-lien loans, mezzanine debt, as well as preferred and common equity co-investments.

Further Reading

Analyst Recommendations for Crescent Capital BDC (NASDAQ:CCAP)

Receive News & Ratings for Crescent Capital BDC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Crescent Capital BDC and related companies with MarketBeat.com's FREE daily email newsletter.